摘要
目的:探讨不同剂量他汀对急性心肌梗死炎症因子超敏 C-反应蛋白(hs-CRP)、白细胞介素-6(IL-6)的影响。方法选取2014年1月至2015年6月治疗并接受急诊冠状动脉支架植入术的急性心肌梗死患者102例,给予抗栓、扩张冠状动脉等治疗,将其随机分为两组,一组口服20 mg 阿托伐他汀,另一组口服40 mg 阿托伐他汀,入院即刻、用药1周、用药2周抽取静脉血,检测 hs-CRP、IL-6、心肌酶等,进行组内及组间比较 hs-CRP、IL-6动态变化。结果组内比较:1周后40 mg 组 hs-CRP、IL-6水平较治疗前降低,差异有统计学意义(P 〈0.05);20 mg组 hs-CRP 和 IL-6较基线增高,但差异未见统计学意义;2周后,40 mg 组和20 mg 组 hs-CRP、IL-6水平较治疗前明显降低,差异均有统计学意义(P 〈0.05)。组间比较:1周后40 mg 组 hs-CRP 差值、IL-6差值较20 mg 组明显降低,差异均有统计学意义(P 〈0.05);2周后两组 hs-CRP 差值、IL-6差值比较差异未见统计学意义。结论40 mg阿托伐他汀较20 mg 阿托他汀能抑制急性心肌梗死早期(发病1周时)炎症反应。
Objective To investigate the effect of different doses of atorvastatin on levels of hs-CRP and IL-6 in patients with acute myodial infarction. Methods One hundred and two patients with acute myocardial infarction from January 2014 to June 2015 received anti-thromb,dilating-coronary, emergency coronary stenting operation and so on. They were randomly divided into two groups:one group (n = 50)was administrated with 40 mg atorvastatin,the other group(n = 52)was administrated with 40 mg atorvastatin. The serum leves of hs-CRP,IL-6 and myocardial enzymes were measured on admis-sion,1 week,2 weeks after oral atorvastatin,the dynamic changes of hs-CRP and IL-6 were compared for inner-group and inter-group. Results Inner-group comparison:the levels of hs-CRP and IL-6 in group 40 mg atorvastatin 1 week after oral atorvastatin reduced signifcantly compared with base-linel evels (P 〈 0. 05),while the levels of hs-CRP and IL-6 increased in 20 mg group,there was no significant difference(P 〈 0. 05). The levels of hs-CRP and IL-6 in both groups reduced signifcantly 2 weeks after oral atorvastatin compared with base-line levels(P 〈 0. 05). Inter-group comparison:hs-CRP deviation and IL-6 deviation in 40 mg group were signifcantly lower than those in 20 mg group one week after oral atorvastatin(P 〈 0. 05),while hs-CRP deviation and IL-6 deviation had no significant difference 2 weeks after oral atorvastatin. Conclusions 40 mg atorvastatin has stronger anti-inflammation effects than 20 mg atorvastatin 1 week after oral atorvastatin.
出处
《中国实用医刊》
2016年第17期24-26,共3页
Chinese Journal of Practical Medicine